Skip to main content
OpenTrials

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,583 public trials 830 recruiting studies
Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Recruiting

Long-term Follow-up Registry Study of Equecabtagene Autoleucel Injection

NCT07028970

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Peking University First Hospital Beijing, China
  • People's Hospital of Peking Universit Beijing, China
  • Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, China
  • Tianjin Medical University General Hospital Tianjin, China
View Trial Details
Recruiting

Study of the Safety, Pharmacodynamics and Efficacy of ANB-002 in Patients With Hemophilia B (SAFRAN)

NCT06120582

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Republican Scientific and Practical Center for Radiation Medicine and Human Ecology Homyel, Belarus
  • Minsk Scientific and Practical Center for Surgery, Transplantology and Hematology Minsk, Belarus
  • State Autonomous Institution for Healthcare "Chelyabinsk Regional Clinical Hospital" Chelyabinsk, Russia
  • State budgetary healthcare institution Leningrad Regional Clinical Hospital Gatchina, Russia
View all 17 locations
View Trial Details
Recruiting

Prospective Observational Pilot Study of LMWH Versus UFH as ECMO Anticoagulation in Lung Transplantation

NCT06868823

Conditions
Anticoagulants and Bleeding Disorders, Cardiovascular Diseases, Extracorporeal Membrane Oxygenation (ECMO), +6 more
Locations
  • University Hospital Motol, 2nd Faculty of Medicine, Charles University in Prague and 3rd Department of Surgery, First Faculty of Medicine, Charles University, and Motol University Hospital, Lung Transplant Program Prague, Czech Republic, Czechia
View Trial Details
Recruiting

IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers

NCT06119685

Conditions
Blood Cancer, Blood Protein Disorders, Cardiovascular Diseases, +23 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • Florida Cancer Specialists and Research Institute - Lake Mary Cancer Center Lake Mary, Florida, United States
  • Emory University Hospital Atlanta, Georgia, United States
  • University of Minnesota Minneapolis, Minnesota, United States
View Trial Details

Related conditions